News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
37–72
Matches
253
Sources here
18
Companies here
7
Search results Stored financial headlines

Active search

253 matching headlines

Ticker or company: ACADMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Instacart and Academy Sports + Outdoors Team Up for Same-Day Delivery in as Fast as an Hour

Customers can now shop Academy's national and exclusive private brands across sports, outdoor, apparel, footwear and more at no markups SAN FRANCISCO and KATY, Texas, Aug. 10, 2026 /PRNewswire/ -- Instacart (Nasdaq: CART), the leading grocery technology company in North America, today announced a …

ASO main company
Sharemaestro market context Price below Trend Line 52 weeks -10.1% · Next-week setup positive 55.8% ASO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

First Trust Advisors LP Raises Stock Holdings in Acadia Realty Trust $AKR

First Trust Advisors LP significantly increased its stake in Acadia Realty Trust (NYSE:AKR) by 247.1% in Q1, now holding 82,027 shares valued at $1.57 million. Other institutional investors also adjusted their holdings, with collective institutional ownership at 97.65%. The company maintains a "Moderate Buy" …

AKR main company
Sharemaestro market context Trend signal active 52 weeks +7.2% · Next-week setup positive 55.7% AKR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Sei Investments Co. Lowers Stock Position in ACADIA Pharmaceuticals Inc. $ACAD

Sei Investments Co. significantly reduced its stake in ACADIA Pharmaceuticals Inc. by 31.0% in the first quarter, selling 47,740 shares but still retaining 106,390 shares valued at approximately $2.37 million. Despite this reduction by one institutional investor, others have either increased or initiated positions, …

ACAD main company
Sharemaestro market context Trend signal active 52 weeks +9.7% · Next-week setup negative 41.7% ACAD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Acadian Timber Q2 Earnings Call Highlights

Key Points Interested in Acadian Timber Corp.? Here are five stocks we like better. Q2 results weakened: Revenue fell to $14.6 million from $17.1 million, while adjusted EBITDA dropped to $1.3 million from $2.4 million and net income declined to $1.3 million, or $0.07 …

ADN main company
Sharemaestro market context Trend signal active 52 weeks +2.5% ADN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Acadia Healthcare (ACHC) Is Up 6.4% After Raising 2026 Revenue Outlook Despite Softer Q2 Earnings

Acadia Healthcare (ACHC) reported softer Q2 2026 earnings but saw its stock rise 6.4% after raising its full-year 2026 revenue guidance to US$3.40–US$3.45 billion. This indicates management's confidence in underlying demand, despite a decline in net income and EPS year-over-year. The article suggests that …

ACHC main company
Sharemaestro market context Trend signal active 52 weeks +37.4% ACHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Acadia Pharmaceuticals (ACAD) Stock Gets Fair Value Bump As Analysts Back Daybue Growth

Acadia Pharmaceuticals (ACAD) has seen its fair value price target increased from US$31.80 to US$33.25 per share, driven by positive analyst commentary and strong performance of its drug Daybue. Analysts highlighted Daybue's revenue, the positive European opinion for trofinetide, and anticipated remlifanserin data as …

ACAD main company
Sharemaestro market context Trend signal active 52 weeks +9.7% · Next-week setup negative 41.7% ACAD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

State Street Corporation (ACAD) discloses 5.3% Acadia Pharma stake on 13G

State Street Corporation has disclosed a 5.3% beneficial ownership stake in Acadia Pharmaceuticals Inc. (ACAD) through a Schedule 13G SEC filing. This translates to 9,076,212 shares of common stock, managed across various State Street Global Advisors entities. The filing indicates shared voting power over …

ACAD main company
Sharemaestro market context Trend signal active 52 weeks +9.7% · Next-week setup negative 41.7% ACAD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Results: ACADIA Pharmaceuticals Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) reported strong quarterly results, with revenues exceeding expectations and statutory profit significantly above analyst forecasts. Following these positive results, analysts have increased their earnings per share forecasts for 2026, indicating increased optimism for the company's future. Despite the upgraded earnings …

ACAD main company
Sharemaestro market context Trend signal active 52 weeks +9.7% · Next-week setup negative 41.7% ACAD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Acadia CFO Mark Schneyer sells $587k in company stock

Mark C. Schneyer, CFO of ACADIA PHARMACEUTICALS INC, sold over $587,000 worth of company stock through a pre-arranged trading plan in early August 2026, while also exercising stock options. These transactions occurred as Acadia's stock traded near its 52-week high, coinciding with strong Q2 …

ACAD main company
Sharemaestro market context Trend signal active 52 weeks +9.7% · Next-week setup negative 41.7% ACAD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Daily Brief Australia: Rio Tinto , EBOS Group , Academies Australasia, Adcorp Australia, AdVeritas , Airtasker, Alice Queen Ltd, Aldoro Resources Ltd, Alterity Therapeutics , Accelerate Resources Ltd and more

AKG main company
Sharemaestro market context Price below Trend Line 52 weeks -43.5% · Next-week setup negative 24.4% AKG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

State Street Corporation (AKR) discloses 7.55M Acadia Realty Trust shares in 13G

State Street Corporation has reported a passive ownership stake of 5.3% in Acadia Realty Trust, holding 7,550,636 common shares as of June 30, 2026. The filing, a SCHEDULE 13G, indicates that State Street exercises shared voting power over 6,756,689 shares and shared dispositive power …

AKR main company
Sharemaestro market context Trend signal active 52 weeks +7.2% · Next-week setup positive 55.7% AKR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

El Pasoan wins top award from Acadia Healthcare

Donna Juarez, an El Paso healthcare professional, has been awarded the prestigious Values in Action Peak Award by Acadia Healthcare. Juarez, who serves as the director of military veteran affairs for Rio Vista Behavioral Health, was selected from 500 nominees out of 29,000 employees. …

ACHC main company
Sharemaestro market context Trend signal active 52 weeks +37.4% ACHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Acadia Realty Trust (NYSE:AKR) Announces $0.20 Quarterly Dividend

Acadia Realty Trust (NYSE:AKR) declared a quarterly dividend of $0.20 per share, payable October 15 to shareholders of record September 30, with an annualized yield of 3.9%. The company's current dividend payout ratio is high at 222.2%, indicating that current earnings do not fully …

AKR main company
Sharemaestro market context Trend signal active 52 weeks +7.2% · Next-week setup positive 55.7% AKR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

1 Healthcare Stock Worth Your Attention and 2 We Ignore

1 Healthcare Stock Worth Your Attention and 2 We Ignore From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 18.3% over …

ACHC main company
Sharemaestro market context Trend signal active 52 weeks +37.4% ACHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Acadia Realty Trust (AKR) Stock Down 3.6% but Still Overvalued -- GF Score: 66/100

Acadia Realty Trust (AKR) experienced a 3.6% stock price decline, trading at $20.71, yet is considered overvalued by 14.3% compared to its GF Value™ estimate of $18.12. The company holds an above-average GF Score™ of 66/100, driven by strong momentum but hindered by weak …

AKR main company
Sharemaestro market context Trend signal active 52 weeks +7.2% · Next-week setup positive 55.7% AKR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

A Look at Acadia Healthcare Co Inc (ACHC) After 4.7% Decline -- GF Value $41.52 vs Price $30.73

Acadia Healthcare Co Inc (ACHC) experienced a 4.7% decline, closing at $30.73, and is considered 26.0% undervalued according to GuruFocus' GF Value of $41.52. Despite an "Above Average" GF Score of 69/100, the company faces challenges with unprofitability and negative cash flow, warranting caution …

ACHC main company
Sharemaestro market context Trend signal active 52 weeks +37.4% ACHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

LSV Asset Management reports 5.16% stake in Academy Sports & Outdoors (ASO)

LSV Asset Management has reported a beneficial ownership of 5.16% in Academy Sports & Outdoors, Inc. (ASO) Class A common stock, totaling 3,202,955 shares as of June 30, 2026. The investment adviser holds sole voting power over 2,087,855 shares and sole dispositive power over …

ASO main company
Sharemaestro market context Price below Trend Line 52 weeks -10.1% · Next-week setup positive 55.8% ASO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

FMR LLC discloses 5.5% Acadia Healthcare (ACHC) stake in amended ownership filing

FMR LLC has filed an amended Schedule 13G, disclosing a beneficial ownership of 5.5% in Acadia Healthcare Company, Inc. (ACHC), effective as of June 30, 2026. This translates to 5,015,726.57 shares, with FMR LLC exercising sole voting power over 5,011,333 shares and sole dispositive …

ACHC main company
Sharemaestro market context Trend signal active 52 weeks +37.4% ACHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

H.C. Wainwright reiterates Acadia Pharmaceuticals stock rating

H.C. Wainwright has reiterated a Buy rating and a $37.00 price target for Acadia Pharmaceuticals (NASDAQ: ACAD). The stock is currently trading near its 52-week high, with strong momentum. The firm highlighted the recent closure of enrollment for the Phase 2 RADIANT trial, with …

ACAD main company
Sharemaestro market context Trend signal active 52 weeks +9.7% · Next-week setup negative 41.7% ACAD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Is Academy Sports And Outdoors (ASO) Undervalued After Its Buy Rating And Retail Media Launch?

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Academy Sports and Outdoors stock has delivered a 40.9% gain over the past five years, yet recent share price softness and a strong …

ASO main company
Sharemaestro market context Price below Trend Line 52 weeks -10.1% · Next-week setup positive 55.8% ASO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ACADIA Pharmaceuticals (ACAD) Stock Jumps As Valuation Gap Draws Focus

ACADIA Pharmaceuticals (ACAD) saw its stock jump 6.1% after strong Q2 2026 earnings, reporting increased revenue and net income. The article highlights a significant valuation gap with a P/E of 13 against a discounted cash flow estimate of US$87.67 per share, suggesting potential for …

ACAD main company
Sharemaestro market context Trend signal active 52 weeks +9.7% · Next-week setup negative 41.7% ACAD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ACADIA PHARMACEUTICALS INC Quarterly Earnings Report

ACADIA PHARMACEUTICALS INC (ACAD) has released its unaudited quarterly earnings report for the three and six months ended June 30, 2026. The company reported sufficient liquidity to fund planned operations beyond the next 12 months with $956.5 million in cash, cash equivalents, and investment …

ACAD main company
Sharemaestro market context Trend signal active 52 weeks +9.7% · Next-week setup negative 41.7% ACAD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ACADIA Pharmaceuticals Inc. Stock 12‑Month Price Target Raised to $33.25, Implies 22% Upside

ACADIA Pharmaceuticals Inc.'s average stock price target has been raised from $32.95 to $33.25 by 20 analysts, with a range of $17 to $45 per share. This new target implies a potential upside of approximately 22% based on the August 4 closing price. The …

ACAD main company
Sharemaestro market context Trend signal active 52 weeks +9.7% · Next-week setup negative 41.7% ACAD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Acadia Realty Trust Keeps Quarterly Dividend at $0.20 a Share, Payable Oct. 15 to Holders of Record Sept. 30

Acadia Realty Trust has announced that it will maintain its quarterly dividend at $0.20 per share. This dividend is scheduled to be paid on October 15 to shareholders who are on record as of September 30. The announcement was made on August 5, 2026.

AKR main company
Sharemaestro market context Trend signal active 52 weeks +7.2% · Next-week setup positive 55.7% AKR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context